drugset / Trial / NCT01400932
Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multicenter, randomized, double-blinded, vehicle-controlled, parallel-group study in Japanese subjects with acne vulgaris to demonstrate the efficacy of GI148512 (benzoyl peroxide \[BPO\] 3% gel) when applied once daily for 12 weeks. This study will also evaluate the safety of GI148512 when applied topically once daily for 12 weeks.
Timeline
- Start
- 2011-07
- Primary completion
- 2012-04
- Completion
- 2012-04
Outcome
Met primary endpoint
registry LEAST_SQUARES_MEAN GI148512: -42.9 (Standard Error 1.93) Lesion counts NCT01400932 ↗
registry analysis (superiority or other test); GI148512 vs Vehicle Gel; p <0.001; Mean Difference (Net) -21.0 (95% CI -26.2 to -15.8); ANCOVA NCT01400932 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GI148512 | Unknown | 30 mg | Topical |